RESUMEN
BACKGROUND: The ketogenic diet (KD) has been highly developed in the past for the treatment of epileptic pathological states in children and adults. Recently, the current re-emergence in its popularity mainly focuses on the therapy of cardiometabolic diseases. The KD can also have anti-inflammatory and neuroprotective activities which may be applied to the prevention and/or co-treatment of a diverse range of psychiatric disorders. PURPOSE: This is a comprehensive literature review that intends to critically collect and scrutinize the pre-existing research basis and clinical data of the potential advantageous impacts of a KD on stress, anxiety, depression, schizophrenia and bipolar disorder. METHODS: This literature review was performed to thoroughly represent the existing research in this topic, as well as to find gaps in the international scientific community. In this aspect, we carefully investigated the ultimate scientific web databases, e.g., PubMed, Scopus, and Web of Science, to derive the currently available animal and clinical human surveys by using efficient and representative keywords. RESULTS: Just in recent years, an increasing amount of animal and clinical human surveys have focused on investigating the possible impacts of the KD in the prevention and co-treatment of depression, anxiety, stress, schizophrenia, and bipolar disorder. Pre-existing basic research with animal studies has consistently demonstrated promising results of the KD, showing a propensity to ameliorate symptoms of depression, anxiety, stress, schizophrenia, and bipolar disorder. However, the translation of these findings to clinical settings presents a more complex issue. The majority of the currently available clinical surveys seem to be moderate, usually not controlled, and have mainly assessed the short-term effects of a KD. In addition, some clinical surveys appear to be characterized by enormous dropout rates and significant absence of compliance measurement, as well as an elevated amount of heterogeneity in their methodological design. CONCLUSIONS: Although the currently available evidence seems promising, it is highly recommended to accomplish larger, long-term, randomized, double-blind, controlled clinical trials with a prospective design, in order to derive conclusive results as to whether KD could act as a potential preventative factor or even a co-treatment agent against stress, anxiety, depression, schizophrenia, and bipolar disorder. Basic research with animal studies is also recommended to examine the molecular mechanisms of KD against the above psychiatric diseases.
Asunto(s)
Ansiedad , Trastorno Bipolar , Depresión , Dieta Cetogénica , Esquizofrenia , Estrés Psicológico , Humanos , Esquizofrenia/dietoterapia , Trastorno Bipolar/dietoterapia , Animales , Ansiedad/dietoterapia , Ansiedad/prevención & control , Estrés Psicológico/dietoterapia , Depresión/prevención & control , Depresión/dietoterapiaRESUMEN
Fish oil or its major constituents, namely omega-3 poly-unsaturated fatty acid (n3-PUFA), are popular supplements to improve neurogenesis, neuroprotection, and overall brain functions. Our objective was to probe the implications of fat enriched diet with variable PUFAs supplements in ameliorating social stress (SS). We fed mice on either of the three diet types, namely the n-3 PUFA-enriched diet (ERD, n3:n6= 7:1), a balanced diet (BLD, n3:n6= 1:1) or a standard lab diet (STD, n3:n6= 1:6). With respect to the gross fat contents, the customized special diets, namely ERD and BLD were extreme diet, not reflecting the typical human dietary composition. Aggressor-exposed SS (Agg-E SS) model triggered behavioral deficiencies that lingered for 6 weeks (6w) post-stress in mice on STD. ERD and BLD elevated bodyweights but potentially helped in building the behavioral resilience to SS. STD adversely affected the gene networks of brain transcriptomics associated with the cell mortality, energy homeostasis and neurodevelopment disorder. Diverging from the ERD's influences on these networks, BLD showed potential long-term benefits in combatting Agg-E SS. The gene networks linked to cell mortality and energy homeostasis, and their subfamilies, such as cerebral disorder and obesity remained at the baseline level of Agg-E SS mice on BLD 6w post-stress. Moreover, neurodevelopment disorder network and its subfamilies like behavioral deficits remained inhibited in the cohort fed on BLD 6w post Agg-E SS.
Asunto(s)
Ácidos Grasos Omega-3 , Estrés Psicológico , Animales , Ratones , Dieta , Ácidos Grasos Omega-3/farmacología , Ácidos Grasos Insaturados , Aceites de Pescado/farmacología , Estrés Psicológico/dietoterapia , Estrés Psicológico/prevención & controlRESUMEN
Importance: Being born small for gestational age (SGA) is a leading cause of perinatal morbidity and mortality with no effective prevention or therapy. Maternal suboptimal nutrition and high stress levels have been associated with poor fetal growth and adverse pregnancy outcomes. Objective: To investigate whether structured interventions based on a Mediterranean diet or mindfulness-based stress reduction (stress reduction) in high-risk pregnancies can reduce the percentage of newborns who were born SGA and other adverse pregnancy outcomes. Design, Setting, and Participants: Parallel-group randomized clinical trial conducted at a university hospital in Barcelona, Spain, including 1221 individuals with singleton pregnancies (19-23 weeks' gestation) at high risk for SGA. Enrollment took place from February 1, 2017, to October 10, 2019, with follow-up until delivery (final follow-up on March 1, 2020). Interventions: Participants in the Mediterranean diet group (n = 407) received 2 hours monthly of individual and group educational sessions and free provision of extra-virgin olive oil and walnuts. Individuals in the stress reduction group (n = 407) underwent an 8-week stress reduction program adapted for pregnancy, consisting of weekly 2.5-hour sessions and 1 full-day session. Individuals in the usual care group (n = 407) received pregnancy care per institutional protocols. Main Outcomes and Measures: The primary end point was the percentage of newborns who were SGA at delivery, defined as birth weight below the 10th percentile. The secondary end point was a composite adverse perinatal outcome (at least 1 of the following: preterm birth, preeclampsia, perinatal mortality, severe SGA, neonatal acidosis, low Apgar score, or presence of any major neonatal morbidity). Results: Among the 1221 randomized individuals (median [IQR] age, 37 [34-40] years), 1184 (97%) completed the trial (392 individuals assigned to the Mediterranean diet group, 391 to the stress reduction group, and 401 to the usual care group). SGA occurred in 88 newborns (21.9%) in the control group, 55 (14.0%) in the Mediterranean diet group (odds ratio [OR], 0.58 [95% CI, 0.40-0.84]; risk difference [RD], -7.9 [95% CI, -13.6 to -2.6]; P = .004), and 61 (15.6%) in the stress reduction group (OR, 0.66 [95% CI, 0.46-0.94]; RD, -6.3 [95% CI, -11.8 to -0.9]; P = .02). The composite adverse perinatal outcome occurred in 105 newborns (26.2%) in the control group, 73 (18.6%) in the Mediterranean diet group (OR, 0.64 [95% CI, 0.46-0.90]; RD, -7.6 [95% CI, -13.4 to -1.8]; P = .01), and 76 (19.5%) in the stress reduction group (OR, 0.68 [95% CI, 0.49-0.95]; RD, -6.8 [95% CI, -12.6 to -0.3]; P = .02). Conclusions and Relevance: In this randomized trial conducted at a single institution in Spain, treating pregnant individuals at high risk for SGA with a structured Mediterranean diet or with mindfulness-based stress reduction, compared with usual care, significantly reduced the percentage of newborns with birth weight below the 10th percentile. Due to important study limitations, these findings should be considered preliminary and require replication, as well as assessment in additional patient populations, before concluding that these treatments should be recommended to patients. Trial Registration: ClinicalTrials.gov Identifier: NCT03166332.
Asunto(s)
Dieta Mediterránea , Recién Nacido Pequeño para la Edad Gestacional , Atención Plena , Complicaciones del Embarazo/prevención & control , Embarazo de Alto Riesgo/psicología , Estrés Psicológico/prevención & control , Adulto , Intervalos de Confianza , Dieta Mediterránea/estadística & datos numéricos , Femenino , Humanos , Recién Nacido , Juglans , Oportunidad Relativa , Aceite de Oliva/administración & dosificación , Embarazo , Complicaciones del Embarazo/dietoterapia , Complicaciones del Embarazo/psicología , Resultado del Embarazo , Atención Prenatal/métodos , Atención Prenatal/estadística & datos numéricos , Estrés Psicológico/dietoterapiaRESUMEN
The COVID-19 pandemic has had a significant impact on populations at an economic, health, and on an interpersonal level, it is still unclear how it has affected health-risk behaviors, such as comfort food consumption over time. This study longitudinally examines the effect of the perceived impact of COVID-19 on comfort food consumption and whether this effect is mediated by emotional distress. A convenience sample of 1048 students and university staff (academic and non-academic) from two universities completed monthly online surveys during the COVID-19 pandemic across six waves (W; W1 to W6). Participants reported their perceived impact of COVID-19 (economic, interpersonal, and health), comfort food consumption, and emotional distress (DASS-21). Using structural equation models, we found an indirect longitudinal effect of the perceived impact of COVID-19 (W1) on comfort food consumption (W3 to W6) through increased emotional distress (W2). The perceived negative impact of COVID-19 on comfort food consumption was fully mediated by the emotional distress during the first waves (W3 and W4), ending in a partial mediation in the last waves (W5 and W6). These findings contribute to disentangling the mechanisms by which the perceived impact of COVID-19 affects comfort food consumption over time, and highlight the role of emotional distress. Future interventions should address comfort food consumption by focusing on handling emotional distress during a crisis.
Asunto(s)
COVID-19/psicología , Dieta/psicología , Emociones , Conducta Alimentaria/psicología , Pandemias , Distrés Psicológico , Estrés Psicológico/etiología , Adolescente , Adulto , Anciano , Docentes , Femenino , Conductas Relacionadas con la Salud , Conocimientos, Actitudes y Práctica en Salud , Humanos , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Percepción , SARS-CoV-2 , Estrés Psicológico/dietoterapia , Estudiantes , Encuestas y Cuestionarios , Universidades , Adulto JovenRESUMEN
SCOPE: A growing number of studies have reported the effects of eicosapentaenoic acid (EPA) and terrestrial phospholipids on ameliorating mood disorders. Marine-derived EPA-enriched phospholipids (EPA-PL) exhibit the structural characteristics of EPA and phospholipids. However, the effect of dietary EPA-PL, and the differences between amphiphilic EPA-PL and lyophobic EPA on mood disorders had not been studied. METHODS AND RESULTS: A comparative investigation to determine the effects of dietary EPA-enriched ethyl ester (EPA-EE) and EPA-PL on improving depression- and anxiety-like behavior in a mouse model is performed, induced by 4 week chronic unpredictable mild stress (CUMS) coupled with lipopolysaccharide (LPS) challenge. It is found that dietary 4 week 0.6% (w/w) EPA-PL rescued depression- and anxiety-like behavior to a greater extent than did EPA-EE. Moreover, dietary EPA-PL significantly reduced the immobility time by 56.6%, close to the normal level, in forced swimming test, which revealed a reversal of depression-like behavior. Further studies revealed that dietary EPA-PL regulated immunity, monoamine systems, and the hypothalamic-pituitary-adrenal (HPA) axis by multi-target interactions, including inhibition of neuroinflammation and apoptosis. CONCLUSION: EPA-PL exerted superior effects to EPA-EE in alleviating depression- and anxiety-like behavior. The data suggest potential novel candidate or targeted dietary patterns to prevent and treat mood disorder.
Asunto(s)
Depresión/dietoterapia , Ácido Eicosapentaenoico/farmacología , Enfermedades Neuroinflamatorias/dietoterapia , Fosfolípidos/farmacología , Estrés Psicológico/dietoterapia , Animales , Ansiedad/inducido químicamente , Ansiedad/dietoterapia , Conducta Animal/efectos de los fármacos , Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Encéfalo/patología , Corticosterona/sangre , Depresión/inducido químicamente , Modelos Animales de Enfermedad , Ácido Eicosapentaenoico/análogos & derivados , Ácido Eicosapentaenoico/química , Quinurenina/metabolismo , Lipopolisacáridos/toxicidad , Masculino , Ratones Endogámicos ICR , Enfermedades Neuroinflamatorias/inmunología , Enfermedades Neuroinflamatorias/fisiopatología , Neurotransmisores/metabolismo , Fosfolípidos/química , Bazo/efectos de los fármacos , Bazo/patología , Estrés Psicológico/inmunologíaRESUMEN
We aimed to evaluate the antidepressant activity of deoiled sunflower seeds (SFS), which are rich in tryptophan, in our mouse model and explored a possible mechanism of action. Male C57BL/6J mice were subjected to chronic unpredictable mild stress (CUMS) and were administered a diet containing SFS as the main protein source. SFS alleviated CUMS-induced depression-like behaviors, compared to the effects of a whey protein-based diet. This effect was related to increases in the levels of serotonin, dopamine, norepinephrine, acetylcholine, and brain-derived neurotrophic factor in SFS-fed mice. These changes accompanied the amelioration of inflammatory abnormalities and oxidative stress. SFS increased the aromatic amino acid levels, and the ratio of tryptophan to neutral amino acids. Furthermore, the antidepressant-like effects of SFS were involved in lipid, nucleotide, and amino acid metabolism. In summary, SFS was found to attenuate depression-like symptoms in mice. These antidepressant effects may be related to the increase in the levels of aromatic amino acids and neurotransmitters, amelioration of oxidative stress and inflammation, and the regulation of the levels of abnormal metabolites to the normal levels.
Asunto(s)
Depresión/dietoterapia , Helianthus , Neurotransmisores/farmacología , Estrés Oxidativo/efectos de los fármacos , Semillas/química , Animales , Monoaminas Biogénicas , Peso Corporal/efectos de los fármacos , Factor Neurotrófico Derivado del Encéfalo/genética , Factor Neurotrófico Derivado del Encéfalo/metabolismo , Manipulación de Alimentos , Regulación de la Expresión Génica/efectos de los fármacos , Inflamación , Masculino , Ratones , Ratones Endogámicos C57BL , Neurotransmisores/química , Estrés Psicológico/dietoterapia , SacarosaRESUMEN
BACKGROUND: There has been a rapid increase in the prevalence of psychiatric and psychological disease, and this has attracted interest in identifying modifiable lifestyle factors that may affect an individual's mood. Diet is one potential lifestyle factor that may affect psychological function. AIM: This study aimed to investigate the relationship between adherence to the health-promoting Nordic diet (ND) with neuropsychological function in young women. METHODS: The study comprised 181 female students aged between 18 and 25 years. Psychological function was evaluated using a series of standardized questionnaires, including the Cognitive Ability Questionnaire, Depression Anxiety Stress Scale, Insomnia Severity Index, Epworth Sleep Scale and Quality of Life Questionnaire. A validated food frequency questionnaire, which included 65 types of foods, was used to evaluate the amount of different foods consumed. RESULTS: Evaluation of the dietary composition of the participants showed that the rate of adherence to the ND was positively associated with total energy, carbohydrates, protein, fibre, iron, magnesium, potassium, zinc, folate, phosphorus, vitamin C, thiamine, riboflavin, niacin, vitamins B6 and B12, carotene, whole grain, legumes, cabbage/vegetables, vegetables and fruit (p<0.05). Linear regression showed cabbage/vegetable consumption was inversely related to scores of stress (ß=-0.04; p=0.038) and anxiety (ß=-0.02; p=0.049) and directly associated with the quality-of-life score (0.02; p=0.036). CONCLUSIONS: Adherence to a ND with a high intake of cabbage/vegetables was inversely associated with stress and anxiety scores and directly associated with health-related quality of life.
Asunto(s)
Dieta , Calidad de Vida , Estudiantes/psicología , Adolescente , Adulto , Ansiedad/dietoterapia , Ansiedad/prevención & control , Brassica , Femenino , Humanos , Irán , Encuestas Nutricionales , Países Escandinavos y Nórdicos , Estrés Psicológico/dietoterapia , Estrés Psicológico/prevención & control , Verduras , Adulto JovenRESUMEN
OBJECTIVE: The aim of this study was to examine the effects of eating dried figs on the symptoms of primary dysmenorrhea, perceived stress levels, and quality of life during all menstrual cycles. METHODS: This randomized, placebo-controlled study was performed with 99 midwifery students. Each student was randomly assigned to the placebo (n = 32), cinnamon (n = 34), or dried fig (n = 33) groups. Data were gathered through the Total Dysmenorrhea Score, a descriptive information form, the Visual Analogue Scale, a pain duration assessment form, the Menstrual Distress Questionnaire, the Perceived Stress Scale, and the short version of the World Health Organization Quality of Life Scale-TR. RESULTS: During the 3 menstrual cycles in which the intervention was implemented, the dried-fig group had significantly lower scores for pain severity and duration, menstrual distress, and perceived stress than did those of the cinnamon and placebo groups. In addition, during these 3 cycles, the dried-fig group had significantly higher quality-of-life scores than the cinnamon and placebo groups. CONCLUSION: The results showed that eating dried figs during menstruation decreased pain severity and duration, menstrual symptoms, and perceived stress and increased quality of life.
Asunto(s)
Dismenorrea/dietoterapia , Ficus/química , Frutas , Calidad de Vida , Adolescente , Cinnamomum zeylanicum/química , Dismenorrea/psicología , Femenino , Humanos , Dimensión del Dolor , Índice de Severidad de la Enfermedad , Estrés Psicológico/dietoterapia , Estrés Psicológico/psicología , Encuestas y Cuestionarios , Adulto JovenRESUMEN
This review aims to present a comprehensive state-of-the-art analysis of the bidirectional crosstalk between gut microbiota and the central nervous system (CNS). The literature concerning the potential effects of gut microbiota on psychiatric disorders through neural pathways comprising the 'gut-brain axis' were gathered. In addition, the influence of probiotics and prebiotics and dairy-rich diets combined with the intake of probiotics and prebiotics on gut microbiota and the subsequent relationship with brain function was reviewed. However, a meta-analysis on the effectiveness of probiotic supplementation in psychiatric disorders is lacking. Therefore, a systematic search of PubMed, Embase, Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov databases from January 1969 to December 2019 was conducted. It led to the identification of a total of 844 research articles. Of these, a total of 23 studies met the meta-analysis criteria. Statistical analysis revealed that there was no significant difference in the symptoms of schizophrenia, stress, and anxiety between probiotic and placebo groups, post-intervention. Probiotic administration reduced depressive symptoms among patients with depression in a statistically significant manner (standardised mean difference (SMD) = -0.87; 95% confidence interval (95% confidence interval): -1.66, -0.99; P=0.03). Further evidence from larger and more rigorous studies with longer duration of probiotic administration, as well as well-defined populations, homogenous probiotic intervention and outcome measures, are needed to clarify the potential therapeutic effects of probiotics on psychiatric symptoms. Based on the current literature, it seems that not all probiotic-/prebiotic-/dairy-rich diet-based treatments exhibited a psychobiotic effect on the CNS. Among the parameters determining the success of the given treatment, the most significant were probiotic composition (multi-strain formulation), the quantity of ingested psychobiotics and the duration of the study.
Asunto(s)
Trastornos de Ansiedad/dietoterapia , Dietoterapia/métodos , Microbioma Gastrointestinal/fisiología , Prebióticos/administración & dosificación , Probióticos/uso terapéutico , Esquizofrenia/dietoterapia , Encéfalo/fisiología , Dieta , Humanos , Estrés Psicológico/dietoterapiaRESUMEN
Prevention of stress-induced adverse effects is important for animals and humans to maintain their quality of life (QOL). Stress decreases the productivity of farm animals and induces abnormal behaviors, which is one of the major problems in animal welfare. In humans, stress increases the risk of mental illness which adversely impacts QOL. Stress is, thus, a common health problem for both animals and humans, and stress prevention and promotion of stress resilience could improve animal and human health and QOL. Among various stresses, psychosocial stress experienced by individuals is particularly difficult to prevent and it could, thus, prove beneficial to attempt to increase resilience to psychosocial stress. There exist a few critical interventions for promoting such resilience, environmental enrichment being one. However, this review describes recent progress in nutritional interventions that could confer resilience to psychosocial stress. The efficacy of this intervention is studied in the social defeat model mouse, which is a standard model for studying psychosocial stress. Several nutrients were found to rescue stress vulnerability using the models. Furthermore, probiotics and prebiotics became crucial dietary interventions for combating psychosocial stress. Collectively, dietary intake of appropriate nutrients will be more important for maintaining QOL in animals and humans.
Asunto(s)
Nutrientes/administración & dosificación , Terapia Nutricional , Fenómenos Fisiológicos de la Nutrición/fisiología , Fitoquímicos/administración & dosificación , Prebióticos/administración & dosificación , Probióticos/administración & dosificación , Estrés Psicológico/dietoterapia , Estrés Psicológico/prevención & control , Aminoácidos/administración & dosificación , Fenómenos Fisiológicos Nutricionales de los Animales , Animales , Modelos Animales de Enfermedad , Microbioma Gastrointestinal , Ratones , Péptidos/administración & dosificación , Calidad de Vida , Ratas , Estrés Psicológico/inmunología , Estrés Psicológico/microbiologíaRESUMEN
Major depressive disorder is a stress-related disease associated with brain metabolic dysregulation in the glutamine-glutamate/γ-aminobutyric acid (Gln-Glu/GABA) cycle. Recent studies have demonstrated that microbiome-gut-brain interactions have the potential to influence mental health. The hypothesis of this study was that Lactobacillus rhamnosus JB-1 (LR-JB1™) dietary supplementation has a positive impact on neuro-metabolism which can be quantified in vivo using magnetic resonance spectroscopy (MRS). A rat model of depressive-like disorder, chronic unpredictable mild stress (CUMS), was used. Baseline comparisons of MRS and behavior were obtained in a control group and in a stressed group subjected to CUMS. Of the 22 metabolites measured using MRS, stressed rats had significantly lower concentrations of GABA, glutamate, glutamine + glutathione, glutamate + glutamine, total creatine, and total N-acetylaspartate (tNAA). Stressed rats were then separated into 2 groups and supplemented with either LR-JB1™ or placebo and re-evaluated after 4 weeks of continued CUMS. The LR-JB1™ microbiotic diet restored these metabolites to levels previously observed in controls, while the placebo diet resulted in further significant decrease of glutamate, total choline, and tNAA. LR-JB1™ treated animals also exhibited calmer and more relaxed behavior, as compared with placebo treated animals. In summary, significant cerebral biochemical downregulation of major brain metabolites following prolonged stress were measured in vivo using MRS, and these decreases were reversed using a microbiotic dietary supplement of LR-JB1™, even in the presence of continued stress, which also resulted in a reduction of stress-induced behavior in a rat model of depressive-like disorder.
Asunto(s)
Encéfalo/metabolismo , Trastorno Depresivo/dietoterapia , Suplementos Dietéticos , Lacticaseibacillus rhamnosus , Estrés Psicológico/dietoterapia , Animales , Ácido Aspártico/análogos & derivados , Ácido Aspártico/metabolismo , Conducta Animal , Colina/metabolismo , Trastorno Depresivo/metabolismo , Progresión de la Enfermedad , Ácido Glutámico/metabolismo , Glutamina/metabolismo , Glutatión/metabolismo , Espectroscopía de Resonancia Magnética , Masculino , Ratas , Ratas Wistar , Estrés Psicológico/metabolismo , Ácido gamma-Aminobutírico/metabolismoRESUMEN
INTRODUCTION: There has long been an interest in the effects of diet on mental health, and the interaction of the two with stress; however, the nature of these relationships is not well understood. Although associations between diet, obesity and the related metabolic syndrome (MetS), stress, and mental disorders exist, causal pathways have not been established. METHODS: We reviewed the literature on the relationship between diet, stress, obesity and psychiatric disorders related to stress. RESULTS: Diet and obesity can affect mood through direct effects, or stress-related mental disorders could lead to changes in diet habits that affect weight. Alternatively, common factors such as stress or predisposition could lead to both obesity and stress-related mental disorders, such as depression and posttraumatic stress disorder (PTSD). Specific aspects of diet can lead to acute changes in mood as well as stimulate inflammation, which has led to efforts to assess polyunsaturated fats (PUFA) as a treatment for depression. Bidirectional relationships between these different factors are also likely. Finally, there has been increased attention recently on the relationship between the gut and the brain, with the realization that the gut microbiome has an influence on brain function and probably also mood and behavior, introducing another way diet can influence mental health and disorders. Brain areas and neurotransmitters and neuropeptides that are involved in both mood and appetite likely play a role in mediating this relationship. CONCLUSIONS: Understanding the relationship between diet, stress and mood and behavior could have important implications for the treatment of both stress-related mental disorders and obesity.
Asunto(s)
Dieta/psicología , Trastornos Mentales/metabolismo , Salud Mental , Trastornos por Estrés Postraumático/metabolismo , Estrés Psicológico/metabolismo , Afecto/fisiología , Encéfalo/metabolismo , Encéfalo/microbiología , Depresión/dietoterapia , Depresión/etiología , Depresión/metabolismo , Ácidos Grasos Insaturados/farmacología , Microbioma Gastrointestinal/fisiología , Humanos , Trastornos Mentales/etiología , Neuropéptidos/metabolismo , Neurotransmisores/metabolismo , Obesidad/metabolismo , Obesidad/psicología , Trastornos por Estrés Postraumático/dietoterapia , Trastornos por Estrés Postraumático/etiología , Estrés Psicológico/dietoterapia , Estrés Psicológico/etiologíaRESUMEN
Polyphenols, a category of plant compounds that contain multiple phenol structural units, are widely distributed throughout the plant kingdom and have multiple benefits for human health including anti-obesity, anti-hyperglycemic, and anti-hyperlipidemic effects. Additionally, polyphenols have recently gained attention for their anti-stress effects. In this review article, we summarize physiological responses against exposure to stressors and discuss biomarkers for exposure to stressors that are widely used in animal studies and human trials. We also review commonly used animal models for evaluating anti-stress effects. Finally, we discuss recent findings related to the anti-stress effects of polyphenols evaluated in animal models and human trials, and their putative mechanisms. These emerging data require further investigation in scientific studies and human trials to evaluate the anti-stress effects of polyphenols and their potential use for the prevention of stress-related health problems.
Asunto(s)
Extractos Vegetales/uso terapéutico , Polifenoles/uso terapéutico , Estrés Psicológico/tratamiento farmacológico , Animales , Antiinflamatorios/farmacología , Antiinflamatorios/uso terapéutico , Antioxidantes/farmacología , Antioxidantes/uso terapéutico , Alimentos , Humanos , Fenoles/farmacología , Fenoles/uso terapéutico , Extractos Vegetales/farmacología , Polifenoles/farmacología , Estrés Fisiológico/efectos de los fármacos , Estrés Psicológico/dietoterapiaRESUMEN
This study aimed to investigate the effects of glycated milk casein (Gc) fermented with Lactobacillus rhamnosus 4B15 (FGc) on the intestinal microbiota and physiological and behavioral properties in mice under chronic stress. Mice were administered Gc or FGc for 10 weeks and then exposed to unpredictable chronic mild stress (UCMS) for 7 weeks. FGc administration restored alterations of gut microbiota induced by UCMS. Moreover, FGc significantly reduced the stress-induced increase in serum corticosterone and decrease in serotonin levels. Anxiety-like behaviors induced by UCMS were also significantly decreased in the FGc group. UCMS-induced dysregulation of gene and protein expression related to neuroendocrine function, neuronal development, and inflammation, and gut-blood-brain barrier function was controlled by FGc pre-treatment. These results strongly suggest the protective effects of FGc targeting of intestinal microbiota for abnormal brain activity, which is consistent with the view that FGc plays an important role in regulating stress-related gut-brain axis disorders.
Asunto(s)
Cognición , Lacticaseibacillus rhamnosus/metabolismo , Proteínas de la Leche/metabolismo , Estrés Psicológico/dietoterapia , Estrés Psicológico/psicología , Animales , Bacterias/clasificación , Bacterias/genética , Bacterias/metabolismo , Encéfalo/fisiopatología , Bovinos , Corticosterona/sangre , Productos Lácteos Cultivados/microbiología , Fermentación , Microbioma Gastrointestinal , Humanos , Masculino , Ratones Endogámicos C57BL , Polisacáridos/metabolismo , Serotonina/sangre , Serotonina/metabolismo , Estrés Psicológico/sangre , Estrés Psicológico/microbiologíaRESUMEN
There is a growing emphasis on the role of the microbiota-gut-brain axis as modulator of host behaviour and as therapeutic target for neuropsychiatric disorders. In addition, accumulating evidence suggests that early-life stress can exert long-lasting changes on the brain and microbiota, and this early adversity is associated with increased risk for developing depression in later life. The maternal separation (MS) model in rats is a robust paradigm to study the effects of early-life stress on the microbiota-gut-brain axis. Recently, we have shown that polyphenols, naturally occurring compounds associated with several health benefits, have anti-stress effects in in vitro models. In this study, we assess the therapeutic potential of a variety of both flavonoid and non-flavonoid polyphenols in reversing the impact of MS on behaviour and the microbiota-gut-brain axis. Rats underwent a dietary intervention with the naturally-derived polyphenols xanthohumol and quercetin, as well as with a phlorotannin extract for 8 weeks. Treatment with polyphenols prevented the depressive- and anxiety-like behaviours induced by MS, where xanthohumol effects were correlated with rescue of BDNF plasma levels. In addition, MS resulted in altered brain levels of 5-hydroxyindoleacetic acid (5-HIAA) and dopamine, accompanied by abnormal elevation of plasma corticosterone. Although polyphenols did not reverse neurotransmitter imbalance, xanthohumol normalised corticosterone levels in MS rats. Finally, we explored the impact of MS and polyphenolic diets on the gut microbiota. We observed profound changes in microbial composition and diversity produced by MS condition and by xanthohumol treatment. Moreover, functional prediction analysis revealed that MS results in altered enrichment of pathways associated with microbiota-brain interactions that are significantly reversed by xanthohumol treatment. These results suggest that naturally-derived polyphenols exert antidepressant-like effects in MS rats, which mechanisms could be potentially mediated by HPA regulation, BDNF levels rescue and modulation of the microbiota-gut-brain axis.
Asunto(s)
Antidepresivos , Conducta Animal , Flavonoides , Microbioma Gastrointestinal , Polifenoles , Estrés Psicológico , Animales , Femenino , Masculino , Embarazo , Ratas , Factores de Edad , Antidepresivos/farmacología , Antioxidantes/farmacología , Conducta Animal/efectos de los fármacos , Conducta Animal/fisiología , Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Factor Neurotrófico Derivado del Encéfalo/efectos de los fármacos , Factor Neurotrófico Derivado del Encéfalo/metabolismo , Modelos Animales de Enfermedad , Flavonoides/farmacología , Microbioma Gastrointestinal/efectos de los fármacos , Microbioma Gastrointestinal/fisiología , Polifenoles/farmacología , Propiofenonas/farmacología , Quercetina/farmacología , Ratas Sprague-Dawley , Estrés Psicológico/dietoterapia , Estrés Psicológico/metabolismo , Estrés Psicológico/fisiopatologíaRESUMEN
Introduction: Vitamin and mineral nutritional supplements are becoming increasingly popular as alternative treatments for anxiety and depression, as issues such as side effects from medication, failure to respond to psychotherapy and workforce limitations pose barriers for successful treatment.Areas covered: This review covered double-blind, randomized controlled trials (DBRCTs) testing formulas including at least four vitamins and/or minerals used for the treatment of symptoms of anxiety, stress, or depression in adults not currently taking medication for psychiatric difficulties.Expert opinion: The majority of the 23 trials reviewed were conducted on people without psychological difficulties, limiting the generalizability of the results in people with diagnosed mood and anxiety difficulties. Sixteen studies demonstrated positive effects for symptoms of anxiety, depression, or stress. Micronutrient supplementation in healthy nonclinical adults has limited benefits for mood and anxiety symptoms, although may convey some subtle general improvements. The evidence for adults with physical or mental ill health is more positive although limited by small samples and variability in nutrients studied. Broad-spectrum nutrient products may be more effective than a selected few. While an effect of micronutrients cannot be dismissed, the variability of the studies makes it extremely challenging to identify specific treatment benefits.
Asunto(s)
Ansiedad/dietoterapia , Depresión/dietoterapia , Micronutrientes/farmacología , Estrés Psicológico/dietoterapia , HumanosRESUMEN
Chronic stress and ageing are two of the most important factors that negatively affect cognitive processes such as learning and memory across the lifespan. To date, pharmacological agents have been insufficient in reducing the impact of both on brain health, and thus, novel therapeutic strategies are required. Recent research has focused on nutritional interventions to modify behaviour and reduce the deleterious consequences of both stress and ageing. In this context, emerging evidence indicate that phospholipids, a specific type of fat, are capable of improving a variety of cognitive processes in both animals and humans. The mechanisms underlying these positive effects are actively being investigated but as of yet are not fully elucidated. In this review, we summarise the preclinical and clinical studies available on phospholipid-based strategies for improved brain health across the lifespan. Moreover, we summarize the hypothesized direct and indirect mechanisms of action of these lipid-based interventions which may be used to promote resilience to stress and improve age-related cognitive decline in vulnerable populations.
Asunto(s)
Envejecimiento/metabolismo , Encéfalo/metabolismo , Disfunción Cognitiva/metabolismo , Grasas de la Dieta/farmacología , Microbioma Gastrointestinal , Desarrollo Humano/fisiología , Sistema Hipotálamo-Hipofisario/metabolismo , Fosfolípidos/metabolismo , Estrés Psicológico/metabolismo , Animales , Disfunción Cognitiva/dietoterapia , Humanos , Estrés Psicológico/dietoterapiaRESUMEN
Puberty is a critical period of neural development, and exposure to stress and inflammation during this period is thought to increase vulnerability to mental illness. The gut microbiome influences brain functioning and behavior and impacts mental health. Yet, the role of the gut microbiome during puberty, a period during which mental health conditions tend to onset, remains largely uninvestigated. We first examined age and sex differences in gut microbial changes among CD-1 mice exposed to an immune challenge (lipopolysaccharide; LPS) at 6 weeks of age (during the pubertal stress-sensitive period) or at 10 weeks of age (in adulthood) (Experiment 1). Compared to their adult counterparts, pubertal males and females showed more significant changes in gut microbial composition following LPS treatment, including the depletion of numerous bacterial genera such as Lactobacillus. Given the beneficial effects of Lactobacillus strains on stress and behaviour, we next investigated whether replenishment of the gut with the probiotic Lactobacillus reuteri (L. reuteri) throughout pubertal development would modulate LPS-induced sickness and enduring effects on memory dysfunction, anxiety-like behaviour and stress reactivity in adulthood (Experiment 2). LPS treatment at 6 weeks of age created enduring changes in anxiety-like behaviors among males only. Similarly, only males showed the protective effects of L. reuteri supplementation during puberty in preventing longstanding LPS-induced changes in anxiety-like behavior and stress-induced brain activation. These findings demonstrate that colonizing the gut with L. reuteri during puberty modulates sickness responses and enduring behavioural and neurochemical outcomes in a sex-specific manner. Therefore, colonizing the gut with beneficial microbes may protect against the development of mental illnesses in adulthood.
Asunto(s)
Ansiedad , Conducta Animal , Disfunción Cognitiva , Microbioma Gastrointestinal , Limosilactobacillus reuteri , Probióticos/farmacología , Caracteres Sexuales , Maduración Sexual , Estrés Psicológico , Factores de Edad , Animales , Ansiedad/inducido químicamente , Ansiedad/dietoterapia , Ansiedad/inmunología , Ansiedad/prevención & control , Conducta Animal/efectos de los fármacos , Conducta Animal/fisiología , Disfunción Cognitiva/inducido químicamente , Disfunción Cognitiva/dietoterapia , Disfunción Cognitiva/inmunología , Disfunción Cognitiva/prevención & control , Modelos Animales de Enfermedad , Femenino , Microbioma Gastrointestinal/efectos de los fármacos , Microbioma Gastrointestinal/inmunología , Lipopolisacáridos/inmunología , Lipopolisacáridos/farmacología , Masculino , Ratones , Maduración Sexual/inmunología , Estrés Psicológico/inducido químicamente , Estrés Psicológico/dietoterapia , Estrés Psicológico/inmunología , Estrés Psicológico/prevención & controlRESUMEN
BACKGROUND: Changes in the gut microbiota have been implicated in mood and cognition. In rodents, supplementation with certain bacteria have been shown to alleviate adverse effects of stress on gut microbiota composition and behaviour, but little is known of how the performance of different strains compare to each other. We took a systematic approach to test the efficacy of twelve candidate probiotic strains from ten species/sub-species of Bifidobacterium and Lactobacillus on behaviours and neuroendocrine responses of chronically stressed mice. METHODS: The strains were tested in four screening experiments with non-stressed and chronically stressed vehicle groups. The three most efficacious strains were re-tested to validate the results. Mice were administered a daily oral gavage containing either 1 × 109 colony forming units (CFU) of selected candidate probiotic or saline solution for one week prior to and for three weeks during daily chronic restraint stress. Behavioural tests including the elevated plus maze, open field, novel object recognition, and forced swim test were applied during week five. Corticosterone and adrenocorticotropic hormone (ACTH) were analysed to measure the neuroendocrine response to stress. Plasma and tissue samples were collected for biomarker analyses. RESULTS: Of the twelve candidate probiotics, Lactobacillus paracasei Lpc-37, Lactobacillus plantarum LP12407, Lactobacillus plantarum LP12418 and Lactobacillus plantarum LP12151 prevented stress-associated anxiety and depression-related behaviours from developing compared with chronically stressed vehicle mice. In addition, Lpc-37 improved cognition. CONCLUSION: This systematic screening indicates species- and strain-dependent effects on behavioural outcomes related to stress and further suggests that strains differ from each other in their effects on potential mechanistic outcomes.
Asunto(s)
Ansiedad , Conducta Animal , Bifidobacterium , Disfunción Cognitiva , Depresión , Microbioma Gastrointestinal , Lactobacillus , Probióticos/farmacología , Restricción Física , Estrés Psicológico , Animales , Ansiedad/dietoterapia , Ansiedad/etiología , Ansiedad/metabolismo , Conducta Animal/fisiología , Disfunción Cognitiva/dietoterapia , Disfunción Cognitiva/etiología , Disfunción Cognitiva/metabolismo , Depresión/dietoterapia , Depresión/etiología , Depresión/metabolismo , Suplementos Dietéticos , Microbioma Gastrointestinal/fisiología , Masculino , Ratones , Estrés Psicológico/complicaciones , Estrés Psicológico/dietoterapia , Estrés Psicológico/metabolismoRESUMEN
Objective: This study investigated the effect of a single administration of dark or milk chocolate on blood pressure (BP), heart rate (HR), and double product (DP) in young healthy women at rest and during acute mental stress.Method: Measurements consisted of anthropometry, BP, and HR. Mean arterial BP (MAP) and DP were computed. The relative reactivity of individual variables was quantified as to their percentage change during the rest or test of mental arithmetic (MA) with respect to the respective baseline value. All subjects underwent two tests of MA-one before chocolate administration and the second one 2 hours after chocolate (1 mg/g of body weight) ingestion.Results: Two hours after ingestion at rest, dark chocolate administration resulted in a significant increase in relative values of systolic BP and DP by 5.1% ± 1.4% and 13.7% ± 3.2%, respectively, compared to the responses in the milk chocolate group (-2.4% ± 1.6% and 0.6% ± 3.4%, respectively, p < 0.04 for both comparisons) without changes in diastolic BP, HR, and MAP. During MA-induced acute stress, the relative magnitude of the reactivity of diastolic BP, HR, MAP, and DP decreased by about 10, 16, 8, and 23 percentage points, respectively, 2 hours after ingestion of dark chocolate compared to the relative reactivity determined before dark chocolate ingestion. Milk chocolate failed to affect any of the above-mentioned parameters at rest or during stress.Conclusions: The single oral intake of 85% dark chocolate increased relative values of systolic BP and DP at rest but buffered the reactivity of diastolic BP, HR, MAP, and DP during mental stress, which was not found after ingestion of milk chocolate. Thus, dark chocolate might have a beneficial effect during acute stress due to its ability to buffer cardiovascular reactivity in young healthy women.